Dr Will Townsend is a UCLH Lymphoma Consultant and conducts Phase 1 clinical trials at the UCLH Clinical Research Facility. Our discussion covers the basics of Lymphoma, unpicking the different types, grades, classifications and treatments. At the end we touch upon a current clinical trial involving the use of T-cell Bispecific Antibodies, an off-the-shelf drug that can recruit the patient’s immune system to attack malignant B-cells.
